Drug Safety - Case Reports最新文献

筛选
英文 中文
Acknowledgement to Referees 致推荐人的确认函
Drug Safety - Case Reports Pub Date : 2019-11-16 DOI: 10.1007/s40800-019-0107-6
{"title":"Acknowledgement to Referees","authors":"","doi":"10.1007/s40800-019-0107-6","DOIUrl":"https://doi.org/10.1007/s40800-019-0107-6","url":null,"abstract":"","PeriodicalId":11364,"journal":{"name":"Drug Safety - Case Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77117813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute Kidney Injury Following High-Dose Methotrexate Administration in a Day Care Hospital 日托医院大剂量甲氨蝶呤后急性肾损伤
Drug Safety - Case Reports Pub Date : 2019-11-12 DOI: 10.1007/s40800-019-0106-7
S. Misra, A. Santagostino, G. Dine, Larence Bonhomme Faivre
{"title":"Acute Kidney Injury Following High-Dose Methotrexate Administration in a Day Care Hospital","authors":"S. Misra, A. Santagostino, G. Dine, Larence Bonhomme Faivre","doi":"10.1007/s40800-019-0106-7","DOIUrl":"https://doi.org/10.1007/s40800-019-0106-7","url":null,"abstract":"","PeriodicalId":11364,"journal":{"name":"Drug Safety - Case Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74565678","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fournier’s Gangrene in a Patient with Type 2 Diabetes Mellitus Treated with Empagliflozin: A Case Report 恩格列净治疗2型糖尿病富尼耶坏疽1例
Drug Safety - Case Reports Pub Date : 2019-10-18 DOI: 10.1007/s40800-019-0105-8
Y. Nagano, Naomi Kashiwagi Yakame, H. Aoki, Tamaki Yamakawa, N. Kondo
{"title":"Fournier’s Gangrene in a Patient with Type 2 Diabetes Mellitus Treated with Empagliflozin: A Case Report","authors":"Y. Nagano, Naomi Kashiwagi Yakame, H. Aoki, Tamaki Yamakawa, N. Kondo","doi":"10.1007/s40800-019-0105-8","DOIUrl":"https://doi.org/10.1007/s40800-019-0105-8","url":null,"abstract":"","PeriodicalId":11364,"journal":{"name":"Drug Safety - Case Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74598976","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
A Case of Oropharyngeal Angioedema Following Intravenous Recombinant Tissue Plasminogen Activator (rt-PA) and Mechanical Thrombectomy 静脉注射重组组织纤溶酶原激活剂(rt-PA)和机械取栓术后口咽血管性水肿1例
Drug Safety - Case Reports Pub Date : 2019-10-11 DOI: 10.1007/s40800-019-0104-9
Mohamed Shirazy, A. Chaari, K. Hakim, K. Bousselmi, V. Kauts
{"title":"A Case of Oropharyngeal Angioedema Following Intravenous Recombinant Tissue Plasminogen Activator (rt-PA) and Mechanical Thrombectomy","authors":"Mohamed Shirazy, A. Chaari, K. Hakim, K. Bousselmi, V. Kauts","doi":"10.1007/s40800-019-0104-9","DOIUrl":"https://doi.org/10.1007/s40800-019-0104-9","url":null,"abstract":"","PeriodicalId":11364,"journal":{"name":"Drug Safety - Case Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83199040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Acute Kidney Injury Following Exposure to Calcineurin Inhibitors in a Patient with Idiopathic Membranous Nephropathy 特发性膜性肾病患者暴露于钙调磷酸酶抑制剂后急性肾损伤
Drug Safety - Case Reports Pub Date : 2019-10-05 DOI: 10.1007/s40800-019-0103-x
Maciej Goździk, Agnieszka Płuciennik, Anna Zawiasa-Bryszewska, Maja Nowicka, Z. Nowicka, M. Wagrowska-Danilewicz, I. Kurnatowska
{"title":"Acute Kidney Injury Following Exposure to Calcineurin Inhibitors in a Patient with Idiopathic Membranous Nephropathy","authors":"Maciej Goździk, Agnieszka Płuciennik, Anna Zawiasa-Bryszewska, Maja Nowicka, Z. Nowicka, M. Wagrowska-Danilewicz, I. Kurnatowska","doi":"10.1007/s40800-019-0103-x","DOIUrl":"https://doi.org/10.1007/s40800-019-0103-x","url":null,"abstract":"","PeriodicalId":11364,"journal":{"name":"Drug Safety - Case Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75759840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Allopurinol-Induced Toxic Epidermal Necrolysis 别嘌呤醇诱导的中毒性表皮坏死松解
Drug Safety - Case Reports Pub Date : 2019-09-23 DOI: 10.1007/s40800-019-0101-z
Ignacio Buenrostro-Rubio, J. A. Silva-Villaseñor, Avi William Hatami-Blechner, Juan J Salazar-Del Valle, N. A. Vázquez-Cárdenas, L. Bustamante-Montes, Rafael González-Álvarez
{"title":"Allopurinol-Induced Toxic Epidermal Necrolysis","authors":"Ignacio Buenrostro-Rubio, J. A. Silva-Villaseñor, Avi William Hatami-Blechner, Juan J Salazar-Del Valle, N. A. Vázquez-Cárdenas, L. Bustamante-Montes, Rafael González-Álvarez","doi":"10.1007/s40800-019-0101-z","DOIUrl":"https://doi.org/10.1007/s40800-019-0101-z","url":null,"abstract":"","PeriodicalId":11364,"journal":{"name":"Drug Safety - Case Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86408165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Isoniazid-Induced Systemic Lupus Erythematosus: A Case Report. 异烟肼诱发的系统性红斑狼疮:病例报告
Drug Safety - Case Reports Pub Date : 2019-09-20 DOI: 10.1007/s40800-019-0102-y
Jitendra H Vaghela, Yogesh Solanki, Krishna Lakhani, Bhargav Purohit
{"title":"Isoniazid-Induced Systemic Lupus Erythematosus: A Case Report.","authors":"Jitendra H Vaghela, Yogesh Solanki, Krishna Lakhani, Bhargav Purohit","doi":"10.1007/s40800-019-0102-y","DOIUrl":"10.1007/s40800-019-0102-y","url":null,"abstract":"<p><p>Systemic lupus erythematosus (SLE) can be induced by various medications, such as hydralazine, procainamide, isoniazid, methyldopa, chlorpromazine, quinidine, and minocycline. A patient was admitted complaining of fever with chills and rigor. After being diagnosed with tuberculous meningitis, the patient was given antituberculosis treatment. As the patient did not improve, detailed investigations were conducted, and elevated antinuclear antibody levels were found. The consulting physician diagnosed that the patient was suffering from SLE. As isoniazid is associated with an increased risk of developing SLE, it was suspected as the culprit drug. After withdrawing isoniazid from the antituberculosis treatment regimen, the patient improved and was discharged. Based on the WHO-UMC and Naranjo's causality assessment criteria, an association between the reaction and isoniazid was deemed probable. The reaction was moderately severe (level 4b) according to the modified Hartwig and Siegel scale.</p>","PeriodicalId":11364,"journal":{"name":"Drug Safety - Case Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754470/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74237235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fatal Vitamin K-Dependent Coagulopathy Associated with Cefoperazone/Sulbactam: A Case Report. 致命的维生素k依赖性凝血病与头孢哌酮/舒巴坦:1例报告。
Drug Safety - Case Reports Pub Date : 2019-06-14 DOI: 10.1007/s40800-019-0100-0
Huan-Rong Hu
{"title":"Fatal Vitamin K-Dependent Coagulopathy Associated with Cefoperazone/Sulbactam: A Case Report.","authors":"Huan-Rong Hu","doi":"10.1007/s40800-019-0100-0","DOIUrl":"https://doi.org/10.1007/s40800-019-0100-0","url":null,"abstract":"<p><p>This case report describes a suspected and fatal adverse reaction involving vitamin K-dependent coagulopathy that might be associated with cefoperazone/sulbactam (CPZ/SAM), a combined antimicrobial formulation. We reported a patient diagnosed with acute cerebral infarction and secondary pulmonary infection who was treated with an intravenous infusion of CPZ/SAM at 3 g twice daily. After receiving treatment with CPZ/SAM, the patient developed a fatal adverse reaction of CPZ-induced hemorrhage. The Naranjo assessment score in this report was 5, suggesting that the patient's coagulation function disorder was potentially associated with the use of CPZ/SAM. To prevent vitamin K-dependent coagulopathy caused by CPZ/SAM, it is suggested to avoid cephalosporins in patients with a high risk of bleeding unless the need for cephalosporins is compelling.</p>","PeriodicalId":11364,"journal":{"name":"Drug Safety - Case Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s40800-019-0100-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37330718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
Gastroschisis Following Treatment with High-Dose Methimazole in Pregnancy: A Case Report. 妊娠期大剂量甲巯咪唑治疗胃裂1例。
Drug Safety - Case Reports Pub Date : 2019-05-23 DOI: 10.1007/s40800-019-0099-2
Dyah Purnamasari, Susie Setyowati, Em Yunir, Anandhara Indriani Khumaedi, Dante Saksono Harbuwono
{"title":"Gastroschisis Following Treatment with High-Dose Methimazole in Pregnancy: A Case Report.","authors":"Dyah Purnamasari,&nbsp;Susie Setyowati,&nbsp;Em Yunir,&nbsp;Anandhara Indriani Khumaedi,&nbsp;Dante Saksono Harbuwono","doi":"10.1007/s40800-019-0099-2","DOIUrl":"https://doi.org/10.1007/s40800-019-0099-2","url":null,"abstract":"<p><p>Hyperthyroidism in pregnancy is associated with a increased incidence of low birth weight, preterm birth and admission to the neonatal intensive care unit. However, available treatment options are limited. In this report, we present a case of fetal gastroschisis with a history of intrauterine exposure to methimazole. A 37-year-old woman was diagnosed with Grave's disease 3 years before her pregnancy. She had a poor response to propylthiouracil and required high-dose methimazole before her pregnancy. During the first trimester, she received methimazole 120 mg/day. After her 12th week of pregnancy, she received block-and-replace therapy (levothyroxine [LT4] 50 µg/day) because of the risk of hypothyroidism, and the dose of methimazole was downtitrated to 60 mg/day. Fetal ultrasonography showed fetal growth retardation and gastroschisis at gestational week 33. The relationship between the very high doses of methimazole in the first trimester of pregnancy and the incidence of gastroschisis in this patient was not fully understood because evidence of a relationship between the use of antithyroid drugs in the first trimester and congenital abnormalities in the fetus is lacking. Furthermore block-and-replace therapy is not recommended in pregnancy because it requires a higher dose of methimazole. We recommend preconception counseling and early screening of thyroid function. The counseling should include the best timeline for pregnancy and a discussion of the risks and benefits of hyperthyroidism treatment options.</p>","PeriodicalId":11364,"journal":{"name":"Drug Safety - Case Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s40800-019-0099-2","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37273738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Anaphylactic Reaction to Tc-99m Macrosalb. Tc-99m Macrosalb过敏反应。
Drug Safety - Case Reports Pub Date : 2019-03-05 DOI: 10.1007/s40800-019-0097-4
Nanno Schreuder, Quincy de Hoog, Wouter van der Bruggen, Eugène P van Puijenbroek
{"title":"Anaphylactic Reaction to Tc-99m Macrosalb.","authors":"Nanno Schreuder,&nbsp;Quincy de Hoog,&nbsp;Wouter van der Bruggen,&nbsp;Eugène P van Puijenbroek","doi":"10.1007/s40800-019-0097-4","DOIUrl":"https://doi.org/10.1007/s40800-019-0097-4","url":null,"abstract":"<p><p>A 49-year-old woman developed an anaphylactic reaction to Tc-99m macrosalb used for pulmonary scintigraphy. The patient received an intravenous injection of Tc-99m macrosalb 120 MBq, containing macroaggregates of human albumin 0.14 mg. Within 1 min she developed itching all over her body, an itching throat and dyspnoea. This was followed by urticaria and facial oedema. She was diagnosed with an anaphylactic shock. The patient received clemastine and prednisone, and fully recovered after release from the hospital. According to the Naranjo assessment algorithm, the relationship between the allergic reaction and the administration of Tc-99m macrosalb should be considered as 'probable'.</p>","PeriodicalId":11364,"journal":{"name":"Drug Safety - Case Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s40800-019-0097-4","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37027029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信